IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 50 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $22,000 | +69.2% | 6 | 0.0% | 0.00% | – |
Q3 2020 | $13,000 | -93.3% | 6 | -94.5% | 0.00% | – |
Q2 2020 | $195,000 | +35.4% | 109 | 0.0% | 0.00% | – |
Q1 2020 | $144,000 | -27.3% | 109 | 0.0% | 0.00% | – |
Q4 2019 | $198,000 | -97.2% | 109 | -95.5% | 0.00% | – |
Q3 2019 | $6,982,000 | +8.2% | 2,416 | 0.0% | 0.00% | – |
Q2 2019 | $6,451,000 | -40.5% | 2,416 | -43.2% | 0.00% | – |
Q1 2019 | $10,850,000 | +1729.7% | 4,255 | +1888.3% | 0.00% | – |
Q4 2018 | $593,000 | -86.7% | 214 | -57.2% | 0.00% | – |
Q3 2018 | $4,455,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |